周一“星”视角|免疫调节可溶HLA-G和HLA-E与肺移植术后CLAD恶化及HCMV升高相关;体外清除NETs可恢复废弃猪肺功能

学术   科学   2024-08-19 20:20   四川  



本期胸小星将为大家带来免疫调节可溶HLA-G和HLA-E与肺移植术后CLAD恶化及HCMV升高相关;体外清除NETs可恢复废弃猪肺功能,一起来看看吧!


2017·EATTS 

01

Immunomodulatory soluble HLA-G and HLA-E are associated with rapidly deteriorating CLAD and HCMV viremia after lung transplantation

Laura M Kühner1, Sarah M Berger1, Mila Djinovic1, Philippe L Furlano1, Lisa M Steininger1, Anna-Lena Pirker1, Peter Jaksch2, Elisabeth Puchhammer-Stöckl1, Hannes Vietzen1

1 Center of Virology, Medical University Vienna, Vienna, Austria.

2 Division of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.


Objective: 

Plasma-soluble (s)HLA-G and sHLA-E are immunoregulatory proteins that balance the activation of NKG2A+ immune cells. In lung-transplant recipients (LTRs), dysregulated NKG2A+ natural killer cell responses may result in high-level human cytomegalovirus (HCMV) replication as well as chronic lung allograft dysfunction (CLAD), and especially the development of rapidly deteriorating CLAD is associated with high mortality. 


Methods: 

We thus analyzed the kinetics and function of sHLA-G and sHLA-E in follow-up samples of N = 76 LTRs to evaluate whether these immunoregulatory proteins are associated with the risk for CLAD and high-level HCMV replication.

Results: Here, we demonstrate that rapidly deteriorating CLAD LTRs are hallmarked by continually low (<107 ng/ml) sHLA-G levels. In contrast, high sHLA-E levels were associated with the subsequent development of high-level (>1,000 copies/ml) HCMV episodes.


Conclusion: 

Thus, sHLA-G and sHLA-E may serve as novel biomarkers for the development of rapidly deteriorating CLAD and high-level HCMV replication in LTRs.


[CITATION]: Kühner LM, Berger SM, Djinovic M, et al. Immunomodulatory soluble HLA-G and HLA-E are associated with rapidly deteriorating CLAD and HCMV viremia after lung transplantation, J Heart Lung Transplant, 2024 Jul 25:S1053-2498(24)01747-9. 
[DOI]: 10.1016/j.healun.2024.07.014.
[IF]: 6.4

向下滑动查看所有内容 


免疫调节蛋白——可溶性HLA-G和HLA-E与肺移植术后慢性移植肺功能障碍的迅速恶化以及人巨细胞病毒血症相关

胸“星”外科学术团队兴趣小队成员 何贤 

目的

血浆可溶性HLA-G和sHLA-E作为免疫调节蛋白,可平衡NKG2A+免疫细胞的活化。在肺移植受者(lung-transplant recipients, LTRs)中,NKG2A+自然杀伤细胞的反应失调可能导致人巨细胞病毒(human cytomegalovirus, HCMV)高水平复制以及慢性移植肺功能障碍(chronic lung allograft dysfunction, CLAD),特别是CLAD的迅速恶化与高死亡率相关。

方法

本研究对76例LTRs随访样本中sHLA-G和sHLA-E的动态变化及其生物学功能进行了分析,旨在评估这些免疫调节蛋白是否与CLAD和HCMV高水平复制的风险相关。

结果

本研究证实LTRs中CLAD迅速恶化的标志是持续低水平(<107 ng/ml)的sHLA-G。相反,高水平的sHLA-E与随后高水平(>1,000 copies/ml)的HCMV发作相关。

结论

因此,sHLA-G和sHLA-E可作为LTRs中CLAD迅速恶化和HCMV高水平复制的新型生物标志物。

Figure 1. Kinetics and function of sHLA-G and sHLA-E in lung-transplant recipients (LTRs).

 

Figure 2. Impact of sHLA-E on the high-level viral replication in lung-transplant recipients (LTRs).

2017·EATTS 

02

Restoring discarded porcine lungs by ex vivo removal of neutrophil extracellular traps

Margareta Mittendorfer1, Leif Pierre2, Tibor Huzevka1, Jeremy Schofield3, Simon T Abrams3, Guozheng Wang3, Cheng-Hock Toh4, Nicholas B Bèchet1, Ilma Caprnja1, Gunilla Kjellberg5, Andrew Aswani6, Franziska Olm1, Sandra Lindstedt1

1 Department of Clinical Sciences, Lund University, Lund, Sweden; Department of Cardiothoracic Surgery and Transplantation, Lund University Hospital, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Lund Stem Cell Centre, Lund University, Lund, Sweden.

2 Department of Cardiothoracic Surgery and Transplantation, Lund University Hospital, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden; Lund Stem Cell Centre, Lund University, Lund, Sweden.

3 Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom.

4 Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom; Roald Dahl Haemostasis & Thrombosis Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.

5 Department of Thoracic Surgery and Anaesthesiology, Uppsala University Hospital, Uppsala, Sweden.

6 Department of Critical Care, Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom; Santersus AG, Zurich, Switzerland.

 

Background: 

By causing inflammation and tissue damage, neutrophil extracellular traps (NETs) constitute an underlying mechanism of aspiration-induced lung injury, a major factor of the low utilization of donor lungs in lung transplantation (LTx).


Methods: 

To determine whether NET removal during ex vivo lung perfusion (EVLP) can restore lung function and morphology in aspiration-damaged lungs, gastric aspiration lung injury was induced in 12 pigs. After confirmation of acute respiratory distress syndrome, the lungs were explanted and assigned to NET removal connected to EVLP (treated) (n = 6) or EVLP only (nontreated) (n = 6). Hemodynamic measurements were taken, and blood and tissue samples were collected to assess lung function, morphology, levels of cell-free DNA, extracellular histones, and nucleosomes as markers of NETs, as well as cytokine levels.


Results: 

After EVLP and NET removal in porcine lungs, PaO2/FiO2 ratios increased significantly compared to those undergoing EVLP alone (P = 0.0411). Treated lungs had lower cell-free DNA (P = 0.0260) and lower levels of extracellular histones in EVLP perfusate (P = 0.0260) than nontreated lungs. According to histopathology, treated lungs showed less immune cell infiltration and less edema compared with nontreated lungs, which was reflected in decreased levels of proinflammatory cytokines in EVLP perfusate and bronchoalveolar lavage fluid.


Conclusions: 

To conclude, removing NETs during EVLP improved lung function and morphology in aspiration-damaged donor lungs. The ability to remove NETs during EVLP could represent a new therapeutic approach for LTx and potentially expand the donor pool for transplantation.


[CITATION]: Margareta Mittendorfer, Leif Pierre, Tibor Huzevka, et al. Restoring discarded porcine lungs by ex vivo removal of neutrophil extracellular traps. J Heart Lung Transplant. 2024 Jul 20:S1053-2498(24)01736-4.

[DOI]: 10.1016/j.healun.2024.07.007.

[IF]: 6.4

向下滑动查看所有内容


肺移植前Th2免疫反应的循环指标变化与原发性移植物失功减少相关

胸“星”外科学术团队兴趣小队成员 龚静怡 译


背景

中性粒细胞胞外诱捕网(neutrophil extracellular traps,NETs)通过引发炎症和组织损伤,构成了吸入性肺损伤的一种潜在机制,是肺移植(lung transplantation,LTx)中供肺利用率低的一个主要因素。

方法

本研究旨在确定体外肺灌注(ex vivo lung perfusion,EVLP)期间清除NET是否可恢复吸入性损伤肺的功能和形态,研究诱导12只猪发生胃内容物吸入性肺损伤。确诊急性呼吸窘迫综合征后,将肺移出,进行清除NET的EVLP(实验组)(n = 6)或仅EVLP(对照组)(n = 6)。研究检测了血流动力学,收集了血液和组织样本,以评估肺的功能和形态、细胞游离DNA含量、细胞外组蛋白,NETs标志物核小体的含量,和细胞因子浓度。

结果

实验组相比于对照组猪肺的PaO2/FiO2比值显著增加(P = 0.0411)。与对照组相比,实验组猪肺的细胞游离DNA(P = 0.0260)和EVLP灌注液中细胞外组蛋白(P = 0.0260)水平较低。组织病理学显示,与对照组相比,实验组猪肺的免疫细胞浸润和水肿较少,这说明在EVLP灌流液和支气管肺泡灌洗液中的促炎细胞因子水平降低。

结论

综上,在EVLP期间清除NETs可改善吸入性损伤供体肺的功能和形态。EVLP期间清除NETs可能代表着一种新的LTx修复方法,并具有扩大移植供体库的潜能。

Figure 2. Establishment of acute lung injury following gastric aspiration.


Figure 4. Ex vivo lung perfusion (EVLP) with neutrophil extracellular trap removal improved hemodynamic parameters and lung morphology. 

2017·EATTS 



胸外学术时间
胸外学术时间系胸“星”外科学术团队(EATTS)下特色平台,主要共享胸外科领域最前沿的医学论文及科普。此外还分享医学论文写作的基本技能,旨在为医学专业人士(尤其是胸外专业)或大众提供网络共享平台,让大家一起 EAT 每份胸外盛宴。
 最新文章